Stifel raised the firm’s price target on Colgate-Palmolive to $87 from $81 and keeps a Buy rating on the shares. The firm remains cautious on the Americas – household and personal products group, noting volume growth will likely remain muted, though volume declines have likely bottomed out, the analyst tells investors. Stifel anticipates year-over-year global market shares gains in toothpastes and lessening inflation and benefits from pricing should contribute to gross margin expansion in 2024. Overall, the firm continues to view the stock’s risk/reward favorable at current levels, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CL:
- Colgate-Palmolive price target raised to $90 from $88 at JPMorgan
- Colgate-Palmolive price target raised to $82 from $75 at Barclays
- Colgate-Palmolive price target raised to $88 from $87 at Deutsche Bank
- CL, MDLZ, CELH: Which is the Best Consumer Defensive Stock for 2024?
- Colgate-Palmolive (NYSE:CL): A “Strong Buy” Dividend Aristocrat Stock